$NANO #nanobitix lots of upside!$NANO #nanobitix chart is looking great! The declining trendline is broken and the resistance @ 7.20-7.25 zone is put under pressure right now #long
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.075EUR
−39.70 MEUR
30.06 MEUR
40.21 M
About NANOBIOTIX
Sector
Industry
CEO
Laurent Lévy
Website
Headquarters
Paris
Employees (FY)
102
Founded
2003
ISIN
FR0011341205
FIGI
BBG007R248L5
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange NANOBIOTIX INH. EO-,03 stocks are traded under the ticker 5NR.
We've gathered analysts' opinions on NANOBIOTIX INH. EO-,03 future price: according to them, 5NR price has a max estimate of 15.00 EUR and a min estimate of 10.00 EUR. Watch 5NR chart and read a more detailed NANOBIOTIX INH. EO-,03 stock forecast: see what analysts think of NANOBIOTIX INH. EO-,03 and suggest that you do with its stocks.
Yes, you can track NANOBIOTIX INH. EO-,03 financials in yearly and quarterly reports right on TradingView.
NANOBIOTIX INH. EO-,03 is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
5NR earnings for the last quarter are −0.29 EUR per share, whereas the estimation was −0.75 EUR resulting in a 61.33% surprise. The estimated earnings for the next quarter are −0.31 EUR per share. See more details about NANOBIOTIX INH. EO-,03 earnings.
NANOBIOTIX INH. EO-,03 revenue for the last quarter amounts to 32.90 M EUR despite the estimated figure of 0 EUR. In the next quarter revenue is expected to reach 19.80 M EUR.
5NR net income for the last quarter is −11.60 M EUR, while the quarter before that showed −28.10 M EUR of net income which accounts for 58.71% change. Track more NANOBIOTIX INH. EO-,03 financial stats to get the full picture.
No, 5NR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 2, 2024, the company has 102.00 employees. See our rating of the largest employees — is NANOBIOTIX INH. EO-,03 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANOBIOTIX INH. EO-,03 EBITDA is −28.87 M EUR, and current EBITDA margin is −96.04%. See more stats in NANOBIOTIX INH. EO-,03 financial statements.
Like other stocks, 5NR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANOBIOTIX INH. EO-,03 stock right from TradingView charts — choose your broker and connect to your account.